Authors
Latest:
Management of chronic pelvic painOptimization of care represents a priority and requires an understanding of etiology to effectively diagnose and treat.
Latest:
New Mother's ThumbThe monikers “new mother’s thumb” or “mother’s wrist” stem from the increased incidence of this disorder seen during the third trimester of pregnancy and in the first few months after delivery, especially if breastfeeding.
Latest:
Surgeons Panel DiscussionThree esteemed surgeons discuss technology, weighing the pros and cons of existing and newly developed platforms.
Latest:
Utility of pelvic ultrasound imaging in diagnosing endometriosisFindings and significance for gynecologic surgeons.
Latest:
Creating a patient-positive care environment in your medical practiceA positive strategy to help patients with obesity is to help set realistic goals.
Latest:
Physician burnout and self-careDuring the pandemic, physician self-care and organizational efforts to protect physician wellbeing are vital to maintaining a healthy and able workforce, which in turn enables a strong response to the ongoing health crisis.
Latest:
Study finds attitudes around older motherhood focus on negative outcomesInvestigators argue that much of the language around women who give birth later in life is rooted in ableism and ageism and is out of step with current childbirth trends.
Latest:
Unmet Needs in the Management of Uterine FibroidsMauricio Abrão, MD, and Jessica A. Shepherd, MD, MBA, FACOG, address gaps in care for the treatment of uterine fibroids and share the importance of patient education in disease management.
Latest:
Mind-body resilience for women: A focus on depressionHere’s why we should be paying special attention to women’s depression treatment.
Latest:
“I want to do this for my baby”: The woes of pregnancy and addictionSubstance use disorder may prove to be a significant issue for some mothers. In this article, experts discuss a case of addiction in pregnancy, analyzing the patient's medical history and psychosocial state.
Latest:
CDC’s proposed opioid prescribing guideline: Does it fall short on drug testing?Some research shows the previous guideline may have led to the under-treatment of patients with chronic pain.
Latest:
Summary of Society for Maternal-Fetal Medicine (SMFM) Consult Series #52: Diagnosis and management of fetal growth restrictionA challenge in the prenatal management of FGR is differentiating the constitutionally small fetus with a normal neonatal outcome from one who is pathologically growth restricted and at risk for postnatal complications.
Latest:
Five trends for health systems in 2023Adaptability and flexibility will be needed to deal with for challenges next year.
Latest:
Dermatoses of PregnancyCurbside Consults delivers expert perspectives from physicians outside of the OB/GYN specialty to provide insight into various health issues affecting pregnant women. This new section is the brainchild of Editorial Advisory Board member Christine Isaacs, MD.
Latest:
Beyond the federal anti-kickback statuteProviders can face criminal penalties under The Federal Travel Act & EKRA, too.
Latest:
Achieving equitable breast cancer care: Clinical trials, mental health, and digital therapeuticsDiscussions regarding health equity and access to care have long been implicated in breast cancer. Here, key opinion leaders discuss the latest progress in clinical trial access, digital therapeutics, and other efforts that aim to ameliorate these care gaps.
Latest:
Benefits of extended combined hormonal contraceptive regimensExtended combined hormonal contraceptive regimens, which include prolonged active hormone use and shorter hormone-free intervals, offer increased contraceptive efficacy, reduced menstrual symptoms, and improved management of withdrawal bleeding compared to traditional cyclic use.
Latest:
Study shows the impact of adversity on sleep problems in fetal alcohol spectrum disorderIn this study, investigators focused on children with Fetal Alcohol Spectrum Disorder (FASD), who are known to experience significant sleep disturbances.
Latest:
Using analytics to address gaps in SDOHMore medical and SDOH (social determinants of health) data is available now than ever before to clinicians, health care organizations, and payors. Using this data can lead to better outcomes.
Latest:
Designing your patient’s prenatal care “PATH”Recommendations for maternity care professionals based on MiPATH.
Latest:
SOGH responds to Roe v Wade decisionThe Society of Ob/Gyn Hospitalists released a statement on the Supreme Court Decision overturning Roe v Wade.
Latest:
Postoperative pain managementExploring the available interventions for acute pain management during the preoperative, intraoperative, and postoperative phases of care.
Latest:
The role of the pediatric provider in supporting gender-diverse youthPediatricians, adolescent medicine physicians, and other youth providers can play a crucial role in mitigating this risk by supporting SMGD youth and their families and promoting resilience through inclusive and clinically, culturally competent care.
Latest:
Far more men than women are dying of drug overdosesNIDA study shows significant gender difference, but reasons are uncertain.
Latest:
Unmet Needs in the Management of Uterine FibroidsMauricio Abrão, MD, and Jessica A. Shepherd, MD, MBA, FACOG, address gaps in care for the treatment of uterine fibroids and share the importance of patient education in disease management.
Latest:
Breastfeeding reduces the severity of LRTIs in infantsA recent study examined the links between breastfeeding and preterm birth history with hospitalization duration due to LRTIs in infants and toddlers.
Latest:
Proudly unmatchedRead one ob-gyn’s experience going unmatched and how she navigated the news in this Your Voice.
Latest:
Rosacea: disagnosis and treatments for women, and best interventions for pregnant patientsA 35-year-old woman presents with a rash on her face, which worsened following a sunburn on a beach trip and persisted for more than 6 months. What's the diagnosis?
Latest:
FDA approves novel antifungal treatment for vaginal candidiasisOn June 2, 2021, ibrexafungerp (Brexafemme; Scynexis, Inc) was approved by the FDA for vulvovaginal candidiasis (VVC) in adult women and girls of reproductive age.
